Stellus Capital Investment Co. (NYSE:SCM – Get Free Report) declared a dividend on Wednesday, October 30th, investing.com reports. Shareholders of record on Friday, November 1st will be paid a dividend of 0.1333 per share by the investment management company on Friday, November 15th. This represents a yield of 11.3%. The ex-dividend date of this dividend is Thursday, October 31st.
Stellus Capital Investment has increased its dividend by an average of 18.0% per year over the last three years. Stellus Capital Investment has a dividend payout ratio of 99.4% indicating that its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline. Analysts expect Stellus Capital Investment to earn $1.60 per share next year, which means the company may not be able to cover its $1.60 annual dividend with an expected future payout ratio of 100.0%.
Stellus Capital Investment Price Performance
SCM traded up $0.07 during midday trading on Wednesday, reaching $14.16. 145,052 shares of the company’s stock were exchanged, compared to its average volume of 137,541. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.26 and a quick ratio of 0.26. The stock has a market capitalization of $341.62 million, a PE ratio of 13.11 and a beta of 1.15. The business’s 50-day moving average price is $13.83 and its 200 day moving average price is $13.91. Stellus Capital Investment has a 1-year low of $12.34 and a 1-year high of $14.68.
Stellus Capital Investment Company Profile
Stellus Capital Investment Corporation is a business development company specializing in investments in private middle-market companies. It invests through first lien, second lien, unitranche, and mezzanine debt financing, often with a corresponding equity investment. The fund prefers to invest in US and Canada.
Read More
- Five stocks we like better than Stellus Capital Investment
- What is the Hang Seng index?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Best Aerospace Stocks Investing
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Invest in Biotech Stocks
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Stellus Capital Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stellus Capital Investment and related companies with MarketBeat.com's FREE daily email newsletter.